文献速递间质性肺疾病

基于CT的生物标志物预测间质性肺疾病进展表型:回顾性队列研究

CT-Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study.
PubMed 文献 · Respirology · 2026-08-14

本研究为两中心回顾性队列,纳入245例非IPF的间质性肺疾病患者,采用自动量化系统测量QLF、QGG、QILD、QNL及STP评分。中位随访20.4个月,55.9%患者出现疾病进展;QGG≥10%、QILD≥30%和STP≥30%均为进展的独立预测因素,STP阳性区域的高QILD和QGG与进展风险增加独立相关。

要点

  • QGG≥10%、QILD≥30%和STP≥30%是非IPF ILD疾病进展的独立预测因素。
  • STP阳性区域高QILD和QGG与进展风险增加独立相关。
  • STP评分联合常规定量CT评分可能改善非IPF ILD的风险分层。

核心结论

  • STP评分是预测非IPF ILD疾病进展的有用影像生物标志物,与常规定量CT评分联合可能改善风险分层。

研究设计与样本

  • 回顾性两中心队列研究,纳入245例非IPF的间质性肺疾病患者。
  • 使用自动量化系统测量QLF、QGG、QILD、QNL和STP评分。
  • 疾病进展定义为FVC绝对下降≥5%或DLCO≥10%预测值、死亡或肺移植。

主要发现

  • 245例患者中137例(55.9%)在随访期间出现疾病进展,中位随访20.4个月。
  • Kaplan-Meier分析显示高QGG(≥10%)、高QILD(≥30%)和高STP(≥30%)患者无进展生存时间更短。
  • 调整年龄、性别、FVC和非IPF ILD类型后,QGG≥10%、QILD≥30%和STP≥30%仍为显著预测因素(HR=1.71,p=0.024;HR=1.73,p=0.006;HR=1.58,p=0.020)。
  • STP阳性区域较高的QILD和QGG评分与进展风险增加独立相关,而STP阴性区域较高的QNL与进展风险降低相关。

关键数值与推荐

  • QGG≥10%、QILD≥30%和STP≥30%为疾病进展的独立预测阈值。
  • 疾病进展定义:FVC绝对下降≥5%或DLCO≥10%预测值、死亡或肺移植。

临床怎么用

  • 对非IPF ILD患者可考虑使用STP评分联合QGG、QILD等定量CT指标进行进展风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Prediction of the progressive phenotype from baseline evaluation is challenging due to the variable clinical course of fibrosing interstitial lung disease (ILD). The aim of this study was to evaluate whether the Single Time Point Prediction (STP) score predicts disease progression better than other quantitative scores. METHODS: This is a retrospective two-centre study including patients with ILD other than idiopathic pulmonary fibrosis (IPF). Using an automated quantification system, quantitative lung fibrosis (QLF), quantitative ground-glass opacity (QGG), quantitative ILD (QILD; the sum of reticulation, honeycombing, and ground-glass opacity), quantitative normal lung (QNL), and STP scores were measured. Disease progression (DP) was defined as an absolute decline in forced vital capacity (FVC) ≥ 5% or DLCO ≥ 10% predicted, death or lung transplantation. RESULTS: Of 245 patients, 137 (55.9%) progressed during follow-up (median: 20.4 months). In the Kaplan-Meier analysis, patients with high QGG (≥ 10%), high QILD (≥ 30%), and high STP (≥ 30%) showed shorter DP free survival time than those without. After adjusting for age, sex, FVC, and types of non-IPF ILD, QGG scores ≥ 10%, QILD ≥ 30%, and STP ≥ 30% remained significant predictors of progression (hazard ratio [HR] = 1.71, p = 0.024; HR = 1.73, p = 0.006; and HR = 1.58, p = 0.020, respectively). Furthermore, higher QILD and QGG scores in STP-positive regions were independently associated with increased DP risk, whereas higher QNL in STP-negative regions was associated with lower DP risk. CONCLUSIONS: The STP score is a useful imaging biomarker for predicting DP and, when combined with conventional quantitative CT scores, may improve risk stratification in patients with non-IPF ILD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Oh JH, Song JW, Goldin J, et al. CT-Based Biomarkers for Predicting Progressive Phenotypes in Interstitial Lung Diseases: A Retrospective Cohort Study. Respirology. 2026. PMID: 42601177. doi:10.1002/resp.70299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。